Bibliography
- COLLART F, HUBERMAN E: Cloning and sequence analy-sis of the human and Chinese hamster inosine-5'-mon-ophosphate dehydrogenase cDNA. J. Biol. Chem. (1988) 263:15769–15772.
- CARR SF, PAPP E, WU JC, NATSUMEDA Y: Characteriza-tion of human Type I and Type II IMP dehydrogenase. (1993) 268:27286–27290.
- WANG W, HEDSTROM L: Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase Type II: random addition of substrates and ordered release of products. Biochemistry (1997) 36:8479–8483.
- SINTCHAK MD, FLEMING MA, FUTER 0 et al.: Structure and mechanism of inosine monophosphate dehydro-genase in complex with the immunosuppressant my-cophenolic acid. Cell (1996) 85: 921–930.
- SHERLEY JL: Guanine nucleotide biosynthesis is regu-lated by the cellular p53 concentration. J. Biol. Chem. (1991) 266:24815–24828.
- TSUTANI H, INAI K, IMAMURA S, UEDA T, NAKAMURA T:Induction of cell differentiation by IMPDH antisense oligomer in HL-60 and K652 human leukemia cell lines. In: Purine and Pyrimidine Metabolism in Man VIII. Sahota A, Taylor MW (Eds.), Plenum Press, New York and London (1995):757–760.
- WU JC: Mycophenolic mofetil: molecular mechanism of action. Perspect. Drug Disc. Des. (1994) 2:185–204.
- KOSUGI Y, SAITO Y, WATANABE J, BABA M, SHIGETA S: Antiviral activities of mizoribine and other inosine monophosphate dehydrogenase inhibitors against several ortho- and paramyxoviruses. Antiviral Chem. Chemother. (1994) 5:366–371.
- KERR KM, HEDSTROM L: The roles of conserved car-boxylate residues in IMP dehydrogenase and identifi-cation of a transition state analog. Biochemistry (1997) 36:13365–13373.
- WHITBY FG, LUECKE H, KUHN P et al.: Crystal structure of Tritrichomonas foetus inosine-5'-monophosphate dehydrogenase and the enzyme-product complex. Bio-chemistry (1997) 36:10666–10674.
- LESIAK K, WATANABE KA, MAJUMDAR A et al.: Synthesis of a methylenebis(phosphonate) analogue of myco-phenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD. J. Med. Chem. (1998) 41:618–622.
- MINAKAWA N, TAKEDA T, SASAKI T, MATSUDA A, UEDAT: Synthesis and antitumor activity of 5-ethynyl-1-8-n-ribofuranosylimidazole-4-carboxamide (EICAID ant its derivatives. J. Med. Chem. (1991) 34:778–786.
- WANG W, PAPOV VV, MINAKAWA N, MATSUDA A, BIE-MANN K, HEDSTROM L: Inactivation of inosine 5'-mon-ophosphate dehydrogenase by the antiviral agent 5 -ethyny1-1-0-n-ribofuranosylimidazole--4carboxamide 5'-mono-phosphate. Biochemistry (1996) 35: 95–101.
- ZHANG H-Z, RAO K, CARR SF et al.: Rationally designed inhibitors of inosine monophosphate dehydrogenase. J. Med. Chem. (1997) 40:4–8.
- FRANKLIN TJ, JACOBS VN, JONES G, PLE P: Human colo-rectal carcinoma cells in vitro as a means to assess the metabolism of analogues of mycophenolic acid. Drug Metab. Disp. (1997) 25:367–370.
- GEBEYEHU G, MARQUEZ VE, VAN COTT A et al.: Ribavi-rin, tiazofurin, selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehy-drogenase. J. Med. Chem. (1985) 28:99–105.
- FRANCHETTI P, CAPPELLACCI L, GRIFANTINI M et al.: Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehy-drogenase. J. Med. Chem. (1995) 38:3829–3837.
- FRANCHETTI P, CAPPELLACCI L, SHEIKHA GA et al.: Syn-thesis, structure, and antiproliferative activity of sele-nophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin. J. Med. Chem. (1977) 40:1731–1737.
- KROHN K, HEINS H, WIELCKENS K: Synthesis and cyto-toxic activity of C-glycosidic nicotinamide riboside analogues. J. Med. Chem. (1992) 35: 511–517.
- PANKIEWICZ KW, ZEIDLER J, CISZEWSKI LA et al.: Syn-thesis of isosteric analogues of nicotinamide adenine dinucleotide containing C-nucleotide of nicotinamide or picolinamide. J. Med. Chem. (1993) 36: 1855–1859.
- ZATORSKI A, WATANABE KA, CARR SF, GOLDSTEIN BM,PANKIEWICZ KA: Chemical synthesis of benzamide adenine dinucleotide: inhibition of inosine mono-phosphate dehydrogenase (Types I and II). J. Med. Chem. (1966) 39:2422–2426.
- LI H, HALLOWS WH, PUNZI JS, PANKIEWICZ KW, WATAN-ABE KA, GOLDSTEIN BM: Crystallographic studies of isosteric NAD analogues bound to alcohol dehydroge-nase: specificity and substrate binding in two ternary complexes. Biochemistry (1994) 33:11734–11744.
- FRANCHETTI P, CAPPELLACCI L, PERLINI P etal: Isostericanalogues of nicotinamide adenine dinucleotide de-rived from furanfurin, thiophenfurin, and seleno-phenfurin as mammalian inosine monophosphate dehydrogenase (Type land II) inhibitors. J. Med. Chem. (1988) 41:1702–1707.
- MARQUEZ VE, TSENG CKH, GEBEYEHU G et al.: Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogues stable to phosphodiesterase hydrolysis. J. Med. Chem. (1986) 29:1726–1731.
- LESIAK K, WATANABE KA, MAJUMDAR A et al.: Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleo-side: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity. J. Med. Chem. (1997) 40:2533–2538.
- NIMMERSGERN E, FOX T, FLEMING MA, THOMSON JA: Conformational changes and stabilization of inosine 5'-monophosphate dehydrogenase associated with ligand binding and inhibition by mycophenolic acid. J. Biol. Chem. (1996) 271:19421-19427. Patents